Skip to Content
Merck
CN
  • Smooth muscle specific disruption of the endothelin-A receptor in mice reduces arterial pressure, and vascular reactivity and affects vascular development.

Smooth muscle specific disruption of the endothelin-A receptor in mice reduces arterial pressure, and vascular reactivity and affects vascular development.

Life sciences (2014-01-15)
Anthony J Donato, Lisa A Lesniewski, Deborah Stuart, Ashley E Walker, Grant Henson, Lise Sorensen, Dean Li, Donald E Kohan
ABSTRACT

The role of vascular smooth muscle endothelin A receptors (ETA) in development and normal physiology remains incompletely understood. To address this, mice were generated with smooth muscle-specific knockout (KO) of ETA. Mice were homozygous for loxP-flanked exons 6-8 of the EDNRA gene (floxed) or were also hemizygous for a transgene expressing Cre recombinase under control of the smooth muscle-specific SM22 promoter (KO mice). Genotyping at 17 days postnatal yielded a 10:1 ratio of floxed:KO mice. Smooth muscle actin staining of embryos at day E10.5 revealed increased tortuosity in dorsal aortae while E12.5 embryos had mandibular, vascular and thymic abnormalities. Mice surviving to weaning developed and bred normally. ETA KO mice aged 2-3 months manifested EDNRA gene recombination in all organs tested. Aortas from KO mice had a >90% reduction in ETA mRNA content, but no differences in ET-1 or ETB mRNA levels. Addition of 0.01-100 nM ET-1 to isolated femoral arteries from floxed, but not KO, mice dose-dependently decreased vessel diameter (up to 80% reduction in the presence of ETB blockade). Intravenous infusion of ET-1 into floxed, but not KO, mice increased mean arterial pressure (MAP) (by ~10 mm Hg). Telemetric analysis revealed decreased MAP in KO mice (reduced by ~7-10 mm Hg) when fed a high salt diet. Smooth muscle ETA is important for normal vascular, mandibular and thymic development and is involved in the maintenance of arterial pressure under physiological conditions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethanolamine, purified by redistillation, ≥99.5%
Sigma-Aldrich
Ethanolamine, ACS reagent, ≥99.0%
Sigma-Aldrich
Hydrogen peroxide solution, 34.5-36.5%
Supelco
Aucubin, analytical standard
Millipore
Hydrogen peroxide solution, 3%, suitable for microbiology
Sigma-Aldrich
Ethanolamine, puriss. p.a., ACS reagent, ≥99.0% (GC/NT)
Supelco
Ethanolamine, analytical standard
Sigma-Aldrich
Ethanolamine, ≥98%
Sigma-Aldrich
Ethanolamine, liquid, BioReagent, suitable for cell culture, ≥98%
Sigma-Aldrich
Ethanolamine, ≥99%
Aucubin, primary reference standard
Sigma-Aldrich
Hydrogen peroxide solution, contains inhibitor, 35 wt. % in H2O
Sigma-Aldrich
Hydrogen peroxide solution, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
Supelco
Benzyl alcohol, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Benzyl benzoate, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Nickel(II) chloride, 98%
Supelco
Benzyl benzoate, analytical standard
Sigma-Aldrich
Nickel(II) chloride, anhydrous, powder, 99.99% trace metals basis
Supelco
Benzyl alcohol, analytical standard
Sigma-Aldrich
Benzyl alcohol, ≥99%, FCC, FG
Sigma-Aldrich
Benzyl benzoate, ≥99%, FCC, FG
Sigma-Aldrich
Benzyl benzoate, natural, ≥99%, FG
Sigma-Aldrich
Benzyl alcohol, anhydrous, 99.8%
Sigma-Aldrich
Benzyl benzoate, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Benzyl benzoate, meets USP testing specifications
Trolamine impurity A, European Pharmacopoeia (EP) Reference Standard
Benzyl alcohol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Benzyl alcohol, natural, ≥98%, FG
Supelco
Benzyl benzoate, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Benzyl alcohol, United States Pharmacopeia (USP) Reference Standard